LICENSE AGREEMENTLicense Agreement • August 1st, 2018 • Arqule Inc • Pharmaceutical preparations • England
This License Agreement (this “Agreement”) is made as of April 16, 2018 (the “Effective Date”) by and between (1) ARQULE, INC., a corporation incorporated under the laws of the State of Delaware, US, with its principal place of business at One Wall Street, Burlington, MA 01803, US (“ArQule”); and (2) BASILEA PHARMACEUTICA INTERNATIONAL LIMITED, a corporation incorporated under the laws of Switzerland, with its principal place of business at Grenzacherstrasse 487, 4058 Basel, Switzerland (“Basilea”). ArQule and Basilea are each sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
